Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

Downregulation of CD36 impaired phagocytic capacity and is associated with a proinflammatory phenotype of <i>Mst1</i> deficiency macrophages. حسب Jianyang Li (461703)

الموضوعات:

DataSheet1_Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR... حسب Colton Ladbury (19768281)

"…Purpose/objective(s)<p>Bridging radiation therapy (bRT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). …"

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Participants with virologic suppression or failure at week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

A visual comparison of the associated resistance data from Table 1 with the values of <i>k</i>_cat, <i>K</i>_M, catalytic efficiency (<i>k</i>_cat/<i>... حسب J. Roadnight Sheehan (20141887)

Agreement in the order of district towns in the results of the SD-TOPSIS application in space ‐ combination A vs. B1. حسب Roman Vavrek (13200141)

Superimposition of the cephalometric tracings obtained before and after treatment of case with premolar tooth extraction. حسب Lijuan Liu (136685)

الموضوعات:

Superimposition of the cephalometric tracings obtained before and after treatment of case with mandibular third molar extraction. حسب Lijuan Liu (136685)

الموضوعات:

Typical measurement parameters. حسب Lijuan Liu (136685)

الموضوعات:

Cephalometric measurement points. حسب Lijuan Liu (136685)

الموضوعات: